Orally active KDR tyrosine kinase inhibitor effective in spontaneously metastatic human tumor model Oct. 31, 2001
Positive interaction demonstrated between PI-88 and several cytotoxic agents in animal tumor model Oct. 31, 2001
Inex c-myc antisense oligonucleotide well tolerated in phase I study in combination with cisplatin Oct. 31, 2001
Preliminary findings reported at AACR-NCI-EORTC from ongoing phase I studies of new GARFT inhibitor Oct. 31, 2001
RSS